Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by stockfyon Dec 16, 2020 10:53am
240 Views
Post# 32118350

APHA, TLRY, DTEA

APHA, TLRY, DTEA More consolidation in the marijuana sector is a sure thing.

Also, tea retailer DAVIDsTEA (DTEA) will most likely start selling CBD-infused tea in 2021.

 

DTEA's CEO was thinking of introducing this new product and the CBD-infused edibles are legal now in Canada.

The key question is which company will acquire DTEA. DTEA's CEO will sell because he and his daughter own almost 50% of the company.




<< Previous
Bullboard Posts
Next >>